The purpose of this study is to determine if weekly chemotherapy (i.e. giving paclitaxel or
carboplatin at a lower dose every week) is more effective than standard chemotherapy
(paclitaxel and carboplatin given once every three weeks over 18 weeks) in treating ovarian
cancer. The investigators also want to see if weekly chemotherapy causes more or fewer
side-effects than standard chemotherapy.